Publication
Patterns of Failure and Toxicity after Intensity-Modulated Radiotherapy with Simultaneous Integrated Boost for Head and Neck Cancer
Conference Paper/Poster - Apr 15, 2010
Toepfer Michael, Wille Nadja, Putora Paul Martin, Brügge Detlef, Arn Markus, Schiefer Johann, Plasswilm Ludwig
Units
Contact
Citation
Type
Conference Name
Publisher Proceedings
Publication Date
Pages
Publisher
Brief description/objective
Objective:
Analysis of toxicity as well as patterns of failure in head-and-neck cancer (HNC) following intensity-modulated radiation therapy (IMRT) and simultaneous integrated boost (SIB), with focus on the location of locoregional failures in relation to the chosen target volumes and dose distributions.
Materials and Methods:
Between 09/06 and 06/08 26 patients with HNC (13 Oropharynx, 2 Larynx, 5 Oral cavity, 5 Hypopharynx and 1 CUP) were treated with IMRT and SIB, most of these patients (65%) with concomittand chemotherapy (Cisplatin). The dosimetry plans for patients with either locoregional failure or Grade 3-4 complications were reviewed and fused over the computed tomography images corresponding with the location of the event.
Results:
Median follow up time was 19 months. Patients received a total dose of 54 to 68 Gy with 1.80 to 2.29 Gy per day. 73% (19) patients had Stage IV (M0) disease, 19% (5pts) Stage III and 8% (2pts) Stage II. 10 patients experienced Grade 3-4 toxicity, 5 acute (4 mucositis/ 1 necrosis), 5 late (3 dyphagia/xerostomie, 2 osteonecrosis). 6 patients with Grade 3/4 toxicity were treated with SIB volume > 100 ccm. 3 of 26 patients failed locally (12%), 1 developed recurrent disease in low dose (56 Gy) RT - volume, 2 had persistant tumor within SIB - volume. 4 patients (15%) developed metastatic disease, 4 patients died. 69% of the patients are in complete remission.
Conclusion:
Outcome and toxicity of treatment with IMRT and SIB seem to be acceptable in locally advanced HNC.